GLP-1 agonists appear to attenuate the release of dopamine in the brain’s reward center, particularly the ventral tegmental areas and nucleus accumbens. Consequently, the urge to drink becomes ...
Researchers from the University of California, San Diego, have identified a shared mechanism in the brain that explains how different drugs, such as methamphetamine and PCP (commonly known as “angel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback